Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

3,221 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 605
Recruiting: 316
Ph III recruiting: 30
Growth YoY: +37.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 37.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (571)

clinicaltrialsPublishedShowing 101–150 of 1,379 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01979523	Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal Melanoma	active not recruiting	Phase 2	42	National Cancer Institute (NCI)NIH	3	Aug 6, 2026	clinicaltrials
NCT03991130	High Dose IL-2 in Combination With Anti-PD-1	terminated	Phase 2	6	Gregory DanielsOTHER	1	Aug 6, 2026	clinicaltrials
NCT04221438